BBS12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.59490198825551E-11 |
Normal-vs-Stage2 |
8.35729999981716E-07 |
Normal-vs-Stage3 |
2.22044604925031E-16 |
Normal-vs-Stage4 |
5.57970336600988E-11 |
Stage1-vs-Stage2 |
2.004400E-01 |
Stage1-vs-Stage3 |
2.383900E-04 |
Stage1-vs-Stage4 |
1.685740E-02 |
Stage2-vs-Stage3 |
3.861000E-01 |
Stage2-vs-Stage4 |
7.222400E-01 |
Stage3-vs-Stage4 |
5.327800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62547753035369E-12 |
Normal-vs-AfricanAmerican |
5.99620353369801E-11 |
Normal-vs-Asian |
2.447200E-01 |
Caucasian-vs-AfricanAmerican |
1.659790E-01 |
Caucasian-vs-Asian |
8.102200E-01 |
AfricanAmerican-vs-Asian |
5.727600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.65134572682746E-12 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
1.290000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.36429999994825E-06 |
Normal-vs-Age(41-60Yrs) |
9.09916586522286E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
3.203100E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.148000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.586400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.300400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.808300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.674200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.632600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.959100E-04 |
Normal-vs-Grade 2 |
1.05830011420949E-10 |
Normal-vs-Grade 3 |
1.11022302462516E-14 |
Normal-vs-Grade 4 |
4.44089209850063E-16 |
Grade 1-vs-Grade 2 |
9.424200E-01 |
Grade 1-vs-Grade 3 |
6.046400E-01 |
Grade 1-vs-Grade 4 |
5.544200E-02 |
Grade 2-vs-Grade 3 |
1.084840E-01 |
Grade 2-vs-Grade 4 |
5.94079999999275E-05 |
Grade 3-vs-Grade 4 |
1.878400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.29100000001436E-06 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.91429982976388E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.6627810239811E-12 |
Normal-vs-N1 |
3.86219944914501E-10 |
N0-vs-N1 |
1.097550E-02 |
|
|